Virological and immunological response to three boosted protease inhibitor regimens

The search result changed since you submitted your search request. Documents might be displayed in a different sort order.

Poster presentation: Purpose of the study To compare the virological, immunological and clinical response to three boosted double protease inhibitor (PI) regimens of saquinavir and ritonavir in combination with lopinavir (LOPSAQ), atazanavir (ATSAQ) or fosamprenavir (FOSAQ) without reverse transcriptase inhibitors (RTI) in HIV-positive patients with limited RTI treatment options. ...

Metadaten
Author:	Christian Baumgardt, Christoph Stephan ORCiD GND, Annette Elisabeth Haberl, Hans-Reinhard Brodt GND, Martin Stürmer, Stefan Klauke, Peter Gute, Markus Bickel, Pavel Khaykin, Nils von Hentig, Schlomo Staszewski
URN:	urn:nbn:de:hebis:30-70687
DOI:	https://doi.org/10.1186/1758-2652-11-S1-P32
ISSN:	1758-2652
Parent Title (English):	Journal of the International AIDS Society
Publisher:	Springer
Place of publication:	Berlin ; Heidelberg
Document Type:	Article
Language:	English
Date of Publication (online):	2009/09/20
Date of first Publication:	2008/11/10
Publishing Institution:	Universitätsbibliothek Johann Christian Senckenberg
Contributing Corporation:	Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9–13 November 2008
Release Date:	2009/09/20
Volume:	11
Issue:	(Suppl 1):P32
Page Number:	2
First Page:	1
Last Page:	2
Note:	© 2008 Baumgardt et al; licensee BioMed Central Ltd.
Source:	Journal of the International AIDS Society 2008, 11(Suppl 1):P32 ; doi:10.1186/1758-2652-11-S1-P32 ; from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9–13 November 2008
HeBIS-PPN:	218873328
Institutes:	Medizin / Medizin
Dewey Decimal Classification:	6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):	Deutsches Urheberrecht

Open Access